NCT07559903 ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
| NCT ID | NCT07559903 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-06 |
| Primary Completion | 2031-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-06 with a primary completion date of 2031-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Eligibility Criteria
Inclusion Criteria: * All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB Exclusion Criteria: * Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions
Contact & Investigator
Pratik Sandesara, MD
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT07559903 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07559903 currently recruiting?
Yes, NCT07559903 is actively recruiting participants. Contact the research team at daniel.alexander.gold@emory.edu for enrollment information.
Where is the NCT07559903 trial being conducted?
This trial is being conducted at Phoenix, United States, Fort Lauderdale, United States, Atlanta, United States, Atlanta, United States and 11 additional locations.
Who is sponsoring the NCT07559903 clinical trial?
NCT07559903 is sponsored by Emory University. The principal investigator is Pratik Sandesara, MD at Emory University. The trial plans to enroll 5,000 participants.